Lin, C., Sajeev, G., Stiff, P. J., Brunstein, C. G., Cutler, C., Sanz, G., … Sung, A. D. (2023). Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood. Transplantation and Cellular Therapy, 29(1), 52.e1-52.e9. https://doi.org/10.1016/j.jtct.2022.09.018

Lin, Chenyu, Gautam Sajeev, Patrick J. Stiff, Claudio G. Brunstein, Corey Cutler, Guillermo Sanz, Caroline A. Lindemans, et al. “Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.” Transplantation and Cellular Therapy 29, no. 1 (January 2023): 52.e1-52.e9. https://doi.org/10.1016/j.jtct.2022.09.018.

Lin C, Sajeev G, Stiff PJ, Brunstein CG, Cutler C, Sanz G, et al. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood. Transplantation and Cellular Therapy. 2023 Jan;29(1):52.e1-52.e9.

Lin, Chenyu, et al. “Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.” Transplantation and Cellular Therapy, vol. 29, no. 1, Elsevier BV, Jan. 2023, pp. 52.e1-52.e9. Crossref, doi:10.1016/j.jtct.2022.09.018.

Lin C, Sajeev G, Stiff PJ, Brunstein CG, Cutler C, Sanz G, Lindemans CA, Rezvani AR, Hanna R, Koh LP, Maziarz RT, Hwang WYK, Song Y, Liu Q, Manghani R, Sivaraman S, Signorovitch J, Horwitz ME, Sung AD. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood. Transplantation and Cellular Therapy. Elsevier BV; 2023 Jan;29(1):52.e1-52.e9.